Change in claudication distance from baseline (m) · intermittent claudication
1 finding from 1 review
Absolute claudication distance (change in metres) · intermittent claudication
1 finding from 1 review
Arterial revascularisation · intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Amputation · intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event related to study medication ‐ headache (number of cases) · intermittent claudication
Cilostazol may leads to higher adverse event related to study medication ‐ headache (number of cases) compared with pentoxifylline (low certainty).
1 finding from 1 review
Cardiovascular events · intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (change in points, SF‐36, WIQ) · intermittent claudication
1 finding from 1 review
Absolute claudication distance (change in metres) · intermittent claudication
1 finding from 1 review
Arterial revascularisation · intermittent claudication
It is very uncertain whether cilostazol changes arterial revascularisation (number of cases) compared with placebo (very low certainty).
1 finding from 1 review
Amputation · intermittent claudication
It is very uncertain whether cilostazol changes amputation (number of cases) compared with placebo (very low certainty).
1 finding from 1 review
Adverse event related to study medication ‐ headache (number of cases) · intermittent claudication
Cilostazol probably leads to higher adverse event related to study medication ‐ headache (number of cases) compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular events · intermittent claudication
Cilostazol showed no clear difference in cardiovascular event (number of cases) compared with placebo (low certainty).
1 finding from 1 review
Change in claudication distance from baseline (m) · intermittent claudication
1 finding from 1 review
Quality of life (change in points, SF‐36, WIQ) · intermittent claudication
1 finding from 1 review
MACE · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in MACE compared with aspirin (low certainty).
1 finding from 1 review
Death · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in death compared with aspirin (low certainty).
1 finding from 1 review
All major occlusive vascular events · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intracerebral haemorrhage (ICH) · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in intracerebral haemorrhage (ICH) compared with aspirin (low certainty).
1 finding from 1 review
Functional status ‐ not reported · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found